Targeting ErbB3 activation in drug-resistant ovarian carcinoma cells over-expressing the receptor tyrosine kinase Axl

被引：0
|
作者：
Corno, C. [1 ]
Gatti, L. [1 ]
Carenini, N. [1 ]
Zaffaroni, N. [1 ]
Lanzi, C. [1 ]
Perego, P. [1 ]
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Expt Oncol & Mol Med, Milan, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 69卷
关键词：
D O I：
10.1016/S0959-8049(16)32804-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
206
引用
收藏
页码：S71 / S72
页数：2
相关论文
共 26 条
  • [1] Cross-Talk between Receptor Tyrosine Kinases AXL and ERBB3 Regulates Invadopodia Formation in Melanoma Cells
    Revach, Or-Yam
    Sandler, Oded
    Samuels, Yardena
    Geiger, Benjamin
    CANCER RESEARCH, 2019, 79 (10) : 2634 - 2648
  • [2] Estrogenic Promotion of ErbB2 Tyrosine Kinase Activity in Mammary Tumor Cells Requires Activation of ErbB3 Signaling
    Liu, Bolin
    Ordonez-Ercan, Dalia
    Fan, Zeying
    Huang, Xiaoping
    Edgerton, Susan M.
    Yang, XiaoHe
    Thor, Ann D.
    MOLECULAR CANCER RESEARCH, 2009, 7 (11) : 1882 - 1892
  • [3] MM-111: a novel bispecific antibody targeting ErbB3 with potent anti-tumor activity in ErbB2 over-expressing malignancies.
    Nielsen, U. B.
    Huhalov, A.
    Harms, B.
    Paragas, V
    Adams, S.
    Gu, J.
    Nguyen, S.
    Luus, L.
    Oyama, S.
    Razlog, M.
    Overland, R.
    Wallace, M.
    Kohli, N.
    Feldhaus, M.
    Schoeberl, B.
    McDonagh, C. F.
    CANCER RESEARCH, 2009, 69 (02) : 299S - 299S
  • [4] A multiscale modeling approach to investigate molecular mechanisms of pseudokinase activation and drug resistance in the HER3/ErbB3 receptor tyrosine kinase signaling network
    Telesco, Shannon E.
    Shih, Andrew J.
    Jia, Fei
    Radhakrishnan, Ravi
    MOLECULAR BIOSYSTEMS, 2011, 7 (06) : 2066 - 2080
  • [5] Activation of nonreceptor tyrosine kinase Bmx/Etk mediated by phosphoinositide 3-kinase, epidermal growth factor receptor, and ErbB3 in prostate cancer
    Jiang, Xinnong
    Borgesi, Robert A.
    McKnight, Nicole C.
    Kaur, Ramneet
    Carpenter, Christopher L.
    Balk, Steven P.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (45) : 32689 - 32698
  • [6] Heregulin-induced activation of ErbB3 by EGFR tyrosine kinase activity promotes tumor growth and metastasis in melanoma cells
    Ueno, Yoko
    Sakurai, Hiroaki
    Tsunoda, Satoshi
    Choo, Min-Kyung
    Matsuo, Mitsuhiro
    Koizumi, Keiichi
    Saiki, Ikuo
    INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (02) : 340 - 347
  • [7] The ErbB3 receptor tyrosine kinase negatively regulates Paneth cells by PI3K-dependent suppression of Atoh1
    Almohazey, Dana
    Lo, Yuan-Hung
    Vossler, Claire V.
    Simmons, Alan J.
    Hsieh, Jonathan J.
    Bucar, Edie B.
    Schumacher, Michael A.
    Hamilton, Kathryn E.
    Lau, Ken S.
    Shroyer, Noah F.
    Frey, Mark R.
    CELL DEATH AND DIFFERENTIATION, 2017, 24 (05): : 855 - 865
  • [8] The ErbB3 receptor tyrosine kinase negatively regulates Paneth cells by PI3K-dependent suppression of Atoh1
    Dana Almohazey
    Yuan-Hung Lo
    Claire V Vossler
    Alan J Simmons
    Jonathan J Hsieh
    Edie B Bucar
    Michael A Schumacher
    Kathryn E Hamilton
    Ken S Lau
    Noah F Shroyer
    Mark R Frey
    Cell Death & Differentiation, 2017, 24 : 855 - 865
  • [9] Radiation-induced activation of ErbB2, ErbB3 and IGF-1R in breast carcinoma cells expressing low EGFR levels
    Luo, Xuemei
    Mikkelsen, Ross B.
    CANCER RESEARCH, 2006, 66 (08)
  • [10] The kinase PERK represses translation of the G-protein?coupled receptor LGR5 and receptor tyrosine kinase ERBB3 during ER stress in cancer cells
    Okamoto, Yuka
    Saito, Takuya
    Tani, Yuri
    Toki, Tamami
    Hasebe, Akiko
    Koido, Masaru
    Tomida, Akihiro
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2020, 295 (14) : 4591 - 4603
123